Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-22-027681

CEO bought 100,000 shares at $0.34 ($33,540)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Woods Lori A CEO 2022-11-15 Purchase +100,000 $0.34 $33,540 1,147,038 I: show line 1 in the form
Open-market purchases · 100,000 sh · avg $0.34 · $33,540
Loading xslF345X03/rdgdoc.xml…